- Home
- BNR vs MDCX Comparison
BNR vs MDCX Comparison
Compare BNR & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- MDCX
- Stock Information
- Founded
- BNR 2014
- MDCX 2008
- Country
- BNR China
- MDCX United States
- Employees
- BNR N/A
- MDCX N/A
- Industry
- BNR Medical Specialities
- MDCX
- Sector
- BNR Health Care
- MDCX
- Exchange
- BNR Nasdaq
- MDCX Nasdaq
- Market Cap
- BNR 38.3M
- MDCX 36.2M
- IPO Year
- BNR 2020
- MDCX N/A
- Fundamental
- Price
- BNR N/A
- MDCX $2.44
- Analyst Decision
- BNR
- MDCX Strong Buy
- Analyst Count
- BNR 0
- MDCX 2
- Target Price
- BNR N/A
- MDCX $23.50
- AVG Volume (30 Days)
- BNR 24.0K
- MDCX 410.3K
- Earning Date
- BNR 09-08-2025
- MDCX 11-22-2025
- Dividend Yield
- BNR N/A
- MDCX N/A
- EPS Growth
- BNR N/A
- MDCX N/A
- EPS
- BNR N/A
- MDCX N/A
- Revenue
- BNR $74,862,782.00
- MDCX N/A
- Revenue This Year
- BNR $136.32
- MDCX N/A
- Revenue Next Year
- BNR N/A
- MDCX N/A
- P/E Ratio
- BNR N/A
- MDCX N/A
- Revenue Growth
- BNR 5.20
- MDCX N/A
- 52 Week Low
- BNR $2.18
- MDCX $1.79
- 52 Week High
- BNR $11.12
- MDCX $8.94
- Technical
- Relative Strength Index (RSI)
- BNR N/A
- MDCX 49.21
- Support Level
- BNR N/A
- MDCX $2.33
- Resistance Level
- BNR N/A
- MDCX $2.62
- Average True Range (ATR)
- BNR 0.00
- MDCX 0.23
- MACD
- BNR 0.00
- MDCX -0.02
- Stochastic Oscillator
- BNR 0.00
- MDCX 23.22
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About MDCX Medicus Pharma Ltd. Common Stock
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.